EGFR and non-small cell lung carcinoma: The epidermal growth factor receptor (EGFR) which signals cell proliferation and angiogenesis is commonly and aberrantly over‐activated in NSCLC, which in general shows favorable response to EGFR‐inhibitor treatments (Tu et al., 2017).